Safety evidence

GHK-Cu side effects

Human safety data for GHK-Cu is too limited and formulation-specific to establish reliable incidence rates for systemic research-product use.

Evidence boundary

Reported events must be interpreted in the population, dose, route, and formulation that were actually studied.

Research-vendor identity, purity, sterility, and stability are separate from compound-level safety evidence.

An incomplete adverse-event record does not establish long-term safety.

Human safety data for GHK-Cu is too limited and formulation-specific to establish reliable incidence rates for systemic research-product use.

A small or route-specific study cannot characterize uncommon or long-term adverse effects.
Absence of reported events is not proof that a compound or product is safe.
Research-vendor identity, purity, sterility, endotoxin, and stability remain separate risks.